Viewing Study NCT07086651


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
Study NCT ID: NCT07086651
Status: COMPLETED
Last Update Posted: 2025-12-08
First Post: 2025-07-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module